$AIXI

Xiao-I Corporation reported a GAAP EPS of -$0.11 and revenue of $1.04M for the first half, down 91.0% year-over-year. The company's stock price fell 12.59%.

Chinese EV makers NIO, XPeng, Li Auto, and Leapmotor are supplying self-developed components and technical services externally to diversify revenue. Li Auto confirmed supplying chips and modules. Xpeng's partnership with Volkswagen has boosted its financials, with 4.73B yuan in revenue and 71.4% gross margin from the deal in H1 2026. Li Auto faces sales declines and losses, while NIO has spun off its chip business.

Xiao-I Corporation (Nasdaq: AIXI) announced a reverse ADS split, changing the ratio from 1 ADS to 60 ordinary shares to 1 ADS to 420 ordinary shares. The change, effective September 8, 2026, is equivalent to a 1-for-7 reverse split. ADS holders will automatically exchange 7 old ADSs for 1 new ADS, with fractional shares sold and proceeds distributed. The company's ordinary shares and operations remain unaffected.

Xiao-I Corporation (Nasdaq: AIXI) announced a reverse ADS split, changing the ratio from 1 ADS to 60 ordinary shares to 1 ADS to 420 ordinary shares, effective September 8, 2026. The change will not affect ordinary shares or require action from ADS holders. The company is a leading cognitive intelligence enterprise in China.

Xiao-I Corp. (AIXI) shares dropped over 33% after announcing a one-for-twenty reverse ADS split. The change adjusts the ratio from one ADS representing one-third of an ordinary share to 60. AIXI is still trading on Nasdaq. The company recently won a patent case against Apple, seeking $1.43B in damages. AIXI shares have fallen 70% over the past year.

Investor interest is growing in four small-cap stocks: VivoSim Labs (VIVS), IGC Pharma (IGC), Algorhythm Holdings (RIME), and Xiao-I (AIXI). VIVS reported a $5M milestone payment from Eli Lilly and targets 500%+ revenue growth. IGC beat Q2 estimates and expects Alzheimer's trial results in Q4. RIME is exploring strategic alternatives for its SemiCab AI logistics business. AIXI focuses on enterprise AI solutions. All four stocks trade near $0.30.

BYD said it is expanding beyond electric vehicles into humanoid robotics with its Xiao Di program. The company plans to unveil a humanoid robot in August at its Di Space center, with no full specs or production details yet. BYD executives suggested it could use its dealer network for distribution and is considering an open robotics platform. BYD’s move follows competitors like Aimoga, SAIC-GM, and Xpeng.

BYD said its humanoid robot “Xiao Di” will be shown in early August at BYD’s Di Space experience centers, starting in Zhengzhou, after plans confirmed in late July. The launch follows an FCC move adding certain foreign-produced advanced robotic devices to its Covered List, affecting US import authorization. Reuters reported BYD June global sales rose 5.5% YoY to 403,472 vehicles.

BYD says its humanoid robot “Xiao Di” will appear in early August, after an online leak last month. The teaser indicates it will work inside BYD dealerships as an assistant, greeting visitors, explaining BYD EVs, and running product demos. BYD has not confirmed exact launch timing or whether the robot will be sold to customers.

BYD confirmed its humanoid robot Xiao Di as the US FCC approved import restrictions on newly developed Chinese humanoid robots and connected inverters, citing national security. The rules target models not previously approved, affecting BYD and other Chinese makers. Investors may track BYD’s robotics timeline and potential US market access.